Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ramipril
Drug ID BADD_D01909
Description Ramipril is a prodrug belonging to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. Ramiprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Ramipril may be used in the treatment of hypertension, congestive heart failure, nephropathy, and to reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events.
Indications and Usage For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.
Marketing Status Prescription; Discontinued
ATC Code C09AA05
DrugBank ID DB00178
KEGG ID D00421
MeSH ID D017257
PubChem ID 5362129
TTD Drug ID D01STB
NDC Product Code 50090-5947; 68001-430; 82348-101; 70518-3038; 65862-477; 68382-146; 68382-147; 62135-272; 61570-112; 65841-699; 15308-0300; 61919-157; 76282-673; 57237-223; 63187-277; 68382-144; 71205-029; 0054-0106; 51655-346; 57237-222; 68001-428; 55111-438; 71335-1057; 65862-476; 69037-0051; 65862-320; 63187-854; 76282-671; 0054-0109; 68382-375; 68382-374; 51655-347; 51655-144; 71205-080; 0054-0107; 65862-474; 65862-475; 16729-152; 45865-443; 50090-3059; 55111-440; 63187-644; 17404-1021; 45865-441; 65841-655; 68001-431; 57237-224; 57237-225; 68180-590; 61570-110; 71335-1056; 50090-1118; 60760-481; 0054-0108; 63187-073; 60760-571; 50090-5673; 68001-429; 53104-7573; 71335-0894; 63629-1254; 65841-701; 68382-377; 62135-274; 61570-120; 68382-145; 55111-439; 63187-915; 63187-816; 50090-5730; 68180-591; 50090-4597; 62135-273; 16729-155; 61570-111; 65841-657; 68554-0004; 50090-4691; 65841-658; 12854-207; 16729-153; 68382-376; 65841-702; 16729-154; 55111-441; 62135-271; 65841-656; 60760-477; 76282-672; 76282-670; 50090-3873; 61919-179; 65841-700; 70518-1200; 55111-057; 63187-503; 60760-476; 58032-0123; 55700-551; 68180-589
Synonyms Ramipril | Vesdil | Triatec | Altace | Zabien | Ramace | Tritace | Acovil | Delix | Carasel | HOE-498 | HOE 498 | HOE498
Chemical Information
Molecular Formula C23H32N2O5
CAS Registry Number 87333-19-5
SMILES CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Blood pressure decreasedAngiotensin-converting enzymeP12821T8257716395257; 16138565; 9270093; 10535720; 9726242; 10620209; 10880412; 8986921; 10999650
CoughB2 bradykinin receptorP30411T2371410904024; 12522467; 11699055; 15894833
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cardio-respiratory arrest22.02.06.007; 02.03.04.002--Not Available
Cardiogenic shock24.06.02.006; 02.05.01.0030.001799%Not Available
Cardiomyopathy02.04.01.0010.000600%Not Available
Cardiovascular disorder24.03.02.009; 02.01.01.0010.000365%Not Available
Cataract06.06.01.001--
Cellulitis23.09.01.001; 11.02.01.0010.002398%Not Available
Cerebral haemorrhage24.07.04.001; 17.08.01.003--Not Available
Cerebral ischaemia24.04.06.003; 17.08.01.005--
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Cerebrovascular disorder17.08.02.002; 24.03.05.002--Not Available
Chest discomfort22.02.08.001; 08.01.08.019; 02.02.02.0090.007195%Not Available
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.0110.010393%Not Available
Chills15.05.03.016; 08.01.09.0010.002398%
Choking22.02.05.0010.000400%Not Available
Cholelithiasis09.03.01.002--Not Available
Cholestasis09.01.01.001--Not Available
Chronic obstructive pulmonary disease22.03.01.007--Not Available
Circulatory collapse24.06.02.0010.002598%Not Available
Cold sweat23.02.03.002; 08.01.03.0240.001999%Not Available
Colitis07.08.01.0010.001399%
Colitis ulcerative10.02.01.004; 07.08.01.0050.000400%Not Available
Coma17.02.09.0010.001399%Not Available
Compartment syndrome24.04.05.006; 15.05.05.0050.001599%Not Available
Confusional state19.13.01.001; 17.02.03.0050.006995%
Congenital diaphragmatic hernia22.09.02.003; 07.16.01.003; 03.16.03.0010.000799%Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Conjunctivitis allergic10.01.04.002; 06.04.01.0030.000600%Not Available
Constipation07.02.02.001--
Coordination abnormal17.02.02.0040.000600%Not Available
Coronary artery disease24.04.04.006; 02.02.01.001--Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 24 Pages